Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
about
Left ventricular assist devices as a bridge to cardiac transplantation.Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control studyVon Willebrand disease-associated angiodysplasia: a few answers, still many questions.Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis.Von Willebrand factor and von Willebrand disease.Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management.Treatment of Heyde's Syndrome by Aortic Valve ReplacementPathogenesis of aortic stenosis: not just a matter of wear and tearAcquired aortic stenosis.Risk factors for small bowel angioectasia: The impact of visceral fat accumulation.von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).Pharmacotherapy for mechanical circulatory support: a comprehensive review.Impact of adverse events on ventricular assist device outcomes.Treatment of the acquired von Willebrand syndrome.Challenges faced in long term ventricular assist device support.Heyde syndrome revisited: anaemia and aortic stenosis.Natural remedies for non-steroidal anti-inflammatory drug-induced toxicity.Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices.Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.Do clinical characteristics predict the presence of small bowel angioectasias on capsule endoscopy?Anaemia in patients with aortic stenosis: influence on long-term prognosis.Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.Bleeding in continuous flow left ventricular assist device recipients: an acquired vasculopathy?Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement.Platelet concentrates transfusion in cardiac surgery in relation to preoperative point-of-care assessment of platelet adhesion and aggregation.Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management.Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients.Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding.Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year 'real-world' experience.Gastric angiodysplasia in a child with Bernard-Soulier syndrome: efficacy of octreotide in long-term management.Successful treatment of refractory midgut bleeding with ocreotide and corticosteroids in a dialysis patient with suspected sarcoidosis.Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia.Von Willebrand disease in the elderly: clinical perspectives
P2860
Q26999337-3439C327-DCAE-4F80-A207-22649451A5C4Q33709770-B44D03E8-993C-4E19-AC25-758F095743F8Q34329176-72621C02-3D23-40EE-8254-302AFC6B5F71Q34410798-DAB712D0-0C86-474B-855D-AFE7D32E5EE7Q34530389-44D7C723-A37A-4C1C-B348-EED28B80419EQ34656715-DD5C4CEB-6D70-4535-90D2-7362EE800FF8Q35092150-B0320E0D-7EB1-4B21-A1E6-CE209A8DFE25Q35660101-AA6EF7D2-8765-4919-9267-6338DBA15A54Q35706904-F71ECDDD-FE81-42B4-B59D-188E52EEA2B9Q35767911-E5AFA5CE-06CE-485D-BF29-38FCBBCD352DQ37100261-E64089EA-43AD-47A0-8EF5-E8E858928352Q37826020-58E2BA56-69CB-473A-BDB6-102DD963AF0FQ38073665-87C9AF30-5B81-406D-9993-44F99108CCA7Q38636087-B9B5F1A8-1D11-40D8-A1A2-E32B54B2D94FQ38845511-A8219188-0301-4F98-B6C4-4CA24D89C8D5Q38919076-157CEEDF-F156-41C5-83C0-1ED463D20967Q38960539-6BAF7D46-4745-4A18-9336-3DD3A4101691Q39187475-517E9062-E344-494C-A062-3CA948DBC6AFQ39286115-1D826053-F4F2-4596-A2F1-662F34E8811DQ39806267-984C2A39-E724-4658-91BF-E83501C8FB73Q40868709-EEC4A414-8CCC-4898-AFBD-6199A79B60ABQ41395304-5175468D-5789-4A38-AE03-E174FA3897C0Q42369262-D815BB81-88FA-462C-9A47-444620975378Q42378739-6AEB3502-AFD3-4870-A1AB-61231201B3D4Q43160871-85283647-1B42-42DD-9CAF-946DE2579DC7Q44148290-45F6EE23-97F8-44B3-B449-294A8F3466B6Q45212716-30E2F311-212F-4D63-8093-E8DAA4A68C6FQ45855120-EF95A75C-9508-4D5A-95DD-246C8680CDA4Q45873770-F35D4206-B8D2-4680-98E9-121A7516DCAFQ46601254-B828CE23-5626-4864-BADD-FF115BE1F31CQ50876219-B395D271-B546-4DBF-9C40-DC9857782CBAQ53150245-7BB65564-DBE5-4116-8897-96C5493D6B6DQ58781583-206F5E1A-5568-45BB-99B5-BB37356C6E03
P2860
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
@ast
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
@en
type
label
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
@ast
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
@en
prefLabel
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
@ast
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
@en
P2093
P356
P1433
P1476
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract.
@en
P2093
Montembault S
Veyradier A
P304
P356
10.1053/GAST.2001.21204
P407
P577
2001-02-01T00:00:00Z